Evaluation of KDR rs34231037 as a predictor of sunitinib efficacy in patients with metastatic renal cell carcinoma. [electronic resource]
Producer: 20180716Description: 227-231 p. digitalISSN:- 1744-6880
- Antineoplastic Agents -- administration & dosage
- Carcinoma, Renal Cell -- drug therapy
- Disease-Free Survival
- Female
- Humans
- Indoles -- administration & dosage
- Kidney Neoplasms -- drug therapy
- Male
- Neoplasm Metastasis
- Pharmacogenomic Variants
- Polymorphism, Single Nucleotide
- Pyrroles -- administration & dosage
- Sunitinib
- Treatment Outcome
- Tumor Burden
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.